1. Home
  2. JAZZ vs CSL Comparison

JAZZ vs CSL Comparison

Compare JAZZ & CSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Jazz Pharmaceuticals plc (Ireland)

JAZZ

Jazz Pharmaceuticals plc (Ireland)

HOLD

Current Price

$236.27

Market Cap

15.0B

Sector

Health Care

ML Signal

HOLD

Logo Carlisle Companies Incorporated

CSL

Carlisle Companies Incorporated

HOLD

Current Price

$341.73

Market Cap

14.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
JAZZ
CSL
Founded
2003
1917
Country
Ireland
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Specialty Chemicals
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
15.0B
14.0B
IPO Year
2007
1994

Fundamental Metrics

Financial Performance
Metric
JAZZ
CSL
Price
$236.27
$341.73
Analyst Decision
Strong Buy
Buy
Analyst Count
14
6
Target Price
$217.57
$401.67
AVG Volume (30 Days)
810.7K
313.6K
Earning Date
05-05-2026
04-23-2026
Dividend Yield
N/A
1.27%
EPS Growth
N/A
N/A
EPS
4.43
3.10
Revenue
$1,618,693,000.00
$5,003,600,000.00
Revenue This Year
$6.22
$2.59
Revenue Next Year
$7.68
$4.50
P/E Ratio
$53.20
$110.11
Revenue Growth
N/A
9.08
52 Week Low
$105.00
$293.43
52 Week High
$243.32
$435.92

Technical Indicators

Market Signals
Indicator
JAZZ
CSL
Relative Strength Index (RSI) 58.56 49.18
Support Level $224.23 $339.39
Resistance Level $243.32 $344.68
Average True Range (ATR) 6.98 9.82
MACD -1.65 0.17
Stochastic Oscillator 60.69 60.48

Price Performance

Historical Comparison
JAZZ
CSL

About JAZZ Jazz Pharmaceuticals plc (Ireland)

Jazz Pharmaceuticals is an Ireland-domiciled biopharmaceutical firm focused primarily on treatments for sleeping disorders and oncology. Jazz has nine approved drugs across neuroscience and oncology indications; its portfolio includes Xyrem and Xywav for narcolepsy, Zepzelca for the treatment of metastatic small cell lung cancer, Rylaze for acute lymphoblastic leukemia, and Vyxeos for acute myeloid leukemia. In May 2021, Jazz acquired GW Pharmaceuticals and gained its leading product, Epidiolex for the treatment of severe, rare forms of epilepsy.

About CSL Carlisle Companies Incorporated

Carlisle Companies Inc is a holding company that manufactures and sells single-ply roofing products and warranted systems and accessories for the commercial building industry. It operates through two segments: Carlisle Construction Materials and Carlisle Weatherproofing Technologies. The majority of revenue comes from Carlisle Construction Materials, and more than half of total revenue is earned in the United States. Carlisle Construction Materials produces premium single-ply roofing products and warranted roof systems, including EPDM, TPO, PVC membrane, and polyiso insulation. Carlisle Weatherproofing Technologies produces building envelope solutions, including waterproofing, moisture protection products, air/vapor barriers, and spray polyurethane foam systems.

Share on Social Networks: